With new drug approvals in hand, GSK looks to expand in Zebulon

Recent respiratory drug approvals for GlaxoSmithKline portend good things for Zebulon. In recent months, GSK (NYSE: GSK) has received U...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.